MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Psychogenic movement disorders(PMD): Clinical features"

  • 2018 International Congress

    Revision of Parkinson’s disease diagnosis during a long-term follow-up

    G. Coarelli, B. Garcin, E. Roze, M. Vidailhet, B. Degos (Bobigny, France)

    Objective: The aim of this work was to describe the features of patients with an incorrect diagnosis of Parkinson’s disease (PD) during a long-term clinical…
  • 2018 International Congress

    Functional motor disorders phenotypes. Lumping or splitting?

    J. Gelauff, J. Rosmalen, J. Stone, J. Gardien, M. Tijssen (Groningen, Netherlands)

    Objective: To study the differences in demographics, symptom characteristics, levels of impairment and motor symptom overlap between functional motor symptom phenotypes. Background: The longstanding discussion…
  • 2018 International Congress

    Update on Convergence Spasm: Review of Psychogenic and Organic Case Reports

    R. Fekete, S. Jankovic (Valhalla, NY, USA)

    Objective: The aim is to evaluate case reports and series of convergence spasm (CS). Background: CS consists of episodes of convergence of the eyes, miosis,…
  • 2018 International Congress

    Quality of Life and Psychiatric Comorbidities Comparisons in Patients with Functional (Psychogenic) and Organic Movement Disorders

    T. Gendre, G. Carle, F. Mesrati, M. Houot, B. Degos, B. Garcin (Créteil, France)

    Objective: To compare the quality of life (QoL) and psychiatric comorbidities of patients with functional (psychogenic) movement disorders (FMD) and patients with organic movements disorders…
  • 2017 International Congress

    Restless Legs Syndrome in Functional Movement Disorders

    T. Serranova, M. Slovak, D. Kemlink, K. Sonka, E. Ruzicka (Prague, Czech Republic)

    Objective: To assess the frequency of restless legs syndrome (RLS) in patients with functional movement disorders (FMD). Background: Sensations related to RLS are varied, often…
  • 2017 International Congress

    Emotion regulation and neuropsychological status in psychogenic subtypes.

    B. Scott, A. Strutt, P. Lundberg-Love, A. Schmitt, J. Jankovic, D. Bowers (Gainesville, FL, USA)

    Objective: To determine whether cognitive dysfunction is associated with emotion regulation strategies and psychological distress in two psychogenic movement disorder (PMD) variants: non-epileptic seizures (PNES)…
  • 2017 International Congress

    Psychogenic abdominal myoclonus in Pregnancy: Case Report

    D. García, P.O. Vargaz, Z. Lopez (Toluca de Lerdo, Mexico)

    Objective: Movement disorders in pregnancy represent a diagnostic challenge due to the poor physiopathological understanding in the extrapyramidal system where the afferent and efferent circuits…
  • 2017 International Congress

    Neurological examination of motor Functional Neurological Disorders: an evidence-based review towards the development of consensus guidelines from the Committee on Research of the ANPA

    S. Aybek, D. Perez, W.C. LaFrance, C. Stephen, R. Shura, S. Glass, S. Ducharme, V. Voon (Bern, Switzerland)

    Objective: To develop evidence-based consensus recommendations for the neurological examination of motor Functional Neurological Disorders (FND)/Conversion Disorder, weakness and abnormal movements, on behalf of the…
  • 2017 International Congress

    Fatigue in Functional Motor Disorders.

    J. Gelauff, E. Kingma, J. Stone, J. Rosmalen, M. Tijssen (Groningen, Netherlands)

    Objective: To investigate fatigue severity and the nature of fatigue in functional motor disorders (FMD). Secondarily, to determine the relationship between fatigue, quality of life,…
  • 2016 International Congress

    Testing for the “whack-a-mole” sign in the movement disorders clinic

    J.E. Park, C. Maurer, M. Villegas, M. Hallett (Bethesda, MD, USA)

    Objective: We aimed to determine the sensitivity and specificity of the “whack-a-mole” sign in our movement disorders clinic population. Background: The “whack-a-mole” sign, characterized as…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley